Category Archives: Government

Lawmakers Unimpressed with Mylan CEO’s Defense of EpiPen Pricing; Fact that She’s a Senator’s Daughter Not Beneficial

Outraged Republican and Democratic lawmakers on Wednesday grilled the head of pharmaceutical company Mylan NV (Amsterdam) about the significant cost increase of its life-saving EpiPens and the profits for a company with… Read more »

Workers Pay More for Health Care as Employers Shift Burden, Says Survey; But Do They Get “Value” for What They Pay For?

High deductible health plans are the new normal, says a report by NPR. Just over half of employees this year have a health insurance policy with a deductible of at… Read more »

FDA Approves First Muscular Dystrophy Drug Despite Thumbs Down by Scientific Panel

Federal regulators granted tentative approval to the first drug for muscular dystrophy, following an intense public campaign from patients and doctors who pushed for the largely unproven medication. The approval… Read more »

It’s the 11th Hour and Congress Still Bargaining Over Zika Funding; Nation’s Health Lies In The Balance

Congressional negotiators on Monday pressed to wrap up a must-do spending bill to prevent an election-season government shutdown and finally provide money to battle the threat of the Zika virus,… Read more »

Trump’s Prospects Starting to Stir as Clinton’s Health Remains a Question

Hillary Clinton’s personal health scare is a new market risk for jittery investors already spooked by central banks poised to disappear into the woodwork in the face of lax money policies. The 68-year-old Democratic… Read more »

CDC Director Warns Zika to Be Sobering, Endemic US Problem; Congress Finally Showing Signs of Action.

A likely surge this fall in the number of US infants born with grave defects will serve as a sobering admonition to members of Congress who’ve stalemated over funds to… Read more »

Medicare’s Forgotten History Shows How to Rescue Obamacare.

In the last few years, even though premiums in the Affordable Care Act’s health insurance marketplaces were rising, most customers could avoid a big price rise by shopping for a… Read more »

U.S. Study Raises New Concern for Zika Spread; Congress Back, but Just 19 Days Left to Solve Zika Funding Impasse.

According to a Reuters report, a new study has found genetic fragments of Zika in the eyes and the tears of laboratory mice infected with the virus–a finding that offers… Read more »

Good News for Mylan after Hellish Week: Another Win in Patent War Over MS Drug; Lawyers on Both Sides Rejoice.

Teva Pharmaceutical Industries Ltd. (Petach Tikva ISR) had a third patent on its top-selling multiple sclerosis drug, Copaxone, invalidated last Thursday by a U.S. agency, a further blow to its… Read more »

Theranos Pulls Zika Test from FDA Review after Problems Flagged; Anyone Else Hear a Death Knell?

Blood-testing firm Theranos Inc. (Palo Alto CA) said it voluntarily withdrew a request to the U.S. Food and Drug Administration for emergency clearance of its new Zika-virus blood test. Theranos… Read more »